Clinical study for MRI in evaluating myocardial and muscular involvment in Duchenne muscular dystrophy carriers

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200055651

Enrollment

Unknown

Registered

2022-01-15

Start date

2022-01-04

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Duchenne muscular dystrophy

Interventions

case series:Nil

Eligibility

Sex/Gender

Female

Age

22 Years to 50 Years

Inclusion criteria

Inclusion criteria: DMD carriers confirmed by genetic testing (including mothers and sisters of DMD children and patients confirmed by genetic testing for other reasons).

Exclusion criteria

Exclusion criteria: MRI examination contraindications, claustrophobia, contrast allergy, severe renal insufficiency (serum creatinine clearance > 120 mmol/L), severe cardiac insufficiency (NYHA-IV grade), frequent atrial fibrillation, thyroid dysfunction.

Design outcomes

Primary

Measure	Time frame
Muscular fat fraction;Myocardial delayed enhancement;	—

Secondary

Measure	Time frame
Myocardial strain;	—

Countries

China

Contacts

Public ContactYingkun Guo

West China Second Hospital, Sichuan University

gykpanda@163.com+86 18180609256

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026